- Porsche SE (PAH3 TH) -0.8%
- Mercedes (MBG TH) -0.8%
- Beiersdorf (BEI TH) -0.9%
- Henkel, Danone Cut as Berenberg Factors in Recession, Costs
- SAP (SAP TH) -1.2%
- Henkel (HEN3 TH) -2.4%
- Henkel, Danone Cut as Berenberg Factors in Recession, Costs
- Thyssenkrupp (TKA TH) -1%
- Evotec SE (EVT TH) -1.3%
- Uniper (UN01 TH) -1.4%
- Telefonica Deutschland (O2D TH) -1.5%
- Delivery Hero (DHER TH) -2.4%
- Deutz (DEZ TH) +0.9%
- flatexDEGIRO (FTK TH) -1.2%
- Bilfinger (GBF TH) -1.4%
- Synlab (SYAB TH) -1.8%
- Haleon (H6D0 TH) +3.4%
- Haleon Rated New Equal-Weight at Barclays; PT 348 pence
- Uniper (UN01 TH) -1.4%
- Infineon (IFX TH) -1.5%
- Watch European Apple Suppliers as Company Said to Slow Hiring
- ASML (ASME TH) -1.6%
- Aroundtown (AT1 TH) -1.7%
- Bechtle (BC8 TH) -1.7%
- United Internet (UTDI TH) -2%
- Verbund (OEWA TH) -2%
- TUI (TUI1 TH) -2.1%
- Henkel (HEN3 TH) -2.3%
- Henkel, Danone Cut as Berenberg Factors in Recession, Costs
- Delivery Hero (DHER TH) -2.4%
After Hours Summary: IBM -4.3% heads lower on earnings; MRTN +2.4% higher on earnings; CDXS -2.3% lower as it names new CEOAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: AXGN +5.5% (guides Q2 revs above consensus; also makes changes to its commercial organization), MRTN +2.4%
Companies trading higher in after hours in reaction to news: MNDT +2.2% (DOJ grants early termination of the waiting period re merger with Google), MARA +0.6% (APLD enters into hosting contract with MARA for 200-MW of Bitcoin mining capacity), LH +0.1% (expands its automated clinical trial kit production line in Belgium), EE +0.1% (signs MOU with Bulgaria's Overgas relating to regasified LNG downstream sales)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: IBM -4.3%, NVTA -2.2% (provides guidance, realigns operations, names new CEO)
Companies trading lower in after hours in reaction to news: CDXS -2.3% (CEO to retire, names new CEO), RARE -0.9% (provides update on GTX-102, including interim data from Phase 1/2 study), ACAD -0.1% (submits NDA for Trofinetide for the treatment of Rett Syndrome), NFLX -0.1% (asking customers in five Latin America countries to pay a fee to use shared passwords, according to Bloomberg)